SPYRE THERAPEUTICS INC

Ticker: SYRE CUSIP: 00773J202 Class: Common Stock

Affinity Asset Advisors, LLC's Holding History (CIK: 0001773195)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,432,591 Value ($000) $46,932 Avg Close $26.13 Range $15.86 - $35.31
Q3 2025
Shares 1,419,299 Value ($000) $23,787 Avg Close $16.31 Range $14.00 - $18.30
Q2 2025
Shares 606,678 Value ($000) $9,082 Avg Close $14.80 Range $10.91 - $19.20
Q1 2025
Shares 481,678 Value ($000) $7,772 Avg Close $20.81 Range $16.13 - $26.01
Q4 2024
Shares 824,328 Value ($000) $19,190 Avg Close $29.32 Range $22.37 - $40.26
Q3 2024
Shares 498,420 Value ($000) $14,659 Avg Close $27.85 Range $23.00 - $32.41
Q2 2024
Shares 513,420 Value ($000) $12,071 Avg Close $33.73 Range $22.19 - $40.84
Q1 2024
Shares 410,000 Value ($000) $15,551 Avg Close $28.97 Range $18.54 - $47.97
Q4 2023
Shares 517,554 Value ($000) $11,138 Avg Close $13.78 Range $8.43 - $22.66
Q3 2023
Shares 242,297 Value ($000) $2,968 Avg Close $13.22 Range $9.53 - $18.00